Home › Funds › Two Sigma Investments › NRIX
Two Sigma Investments position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q3 2025)62.88K sh
Reported value held$580.97K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 91.33K | $1.28M | New |
| Q4 2022 | 36.81K | $404.22K | New |
| Q1 2023 | 11.30K | $100.34K | Reduce |
| Q2 2023 | 48.13K | $480.80K | Add |
| Q3 2023 | 26.76K | $210.31K | Reduce |
| Q4 2023 | 94.77K | $978.05K | Add |
| Q1 2024 | 211.32K | $3.11M | Add |
| Q2 2024 | 60.89K | $1.27M | Reduce |
| Q3 2024 | 50.71K | $1.14M | Reduce |
| Q4 2024 | 135.08K | $2.54M | Add |
| Q1 2025 | 257.52K | $3.06M | Add |
| Q1 2025 | 257.52K | $3.06M | Add |
| Q2 2025 | 158.72K | $1.81M | Reduce |
| Q2 2025 | 158.72K | $1.81M | Reduce |
| Q3 2025 | 62.88K | $580.97K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026
- Goldman Sachs Group 813.59K sh · $19.74M · Q2 2026